Source document or public record

FDA 510(k) K200544 — SmartLyte® Plus Electrolyte Analyzer Na+/K+/Cl-/Ca++/Li+

FDA 510(k) index record K200544. Device: SmartLyte® Plus Electrolyte Analyzer Na+/K+/Cl-/Ca++/Li+. Applicant as listed: Diamond Diagnostics, Inc.. Decision date: 2020-10-01.

OtherU.S. Food and Drug Administration (FDA)2020-10-01

Source

"device_name": "SmartLyte® Plus Electrolyte Analyzer Na+/K+/Cl-/Ca++/Li+"

This entry describes what the document covers; the document itself is the authority. Listing it is not agreement with its conclusions.

Review and references

Reviewer

Automated FDA record verification

Published

2026-10-20

Updated

2026-10-20

Disclaimer

professional use

FDA 510(k) public index record K200544.

Device name: SmartLyte® Plus Electrolyte Analyzer Na+/K+/Cl-/Ca++/Li+. Applicant as listed: Diamond Diagnostics, Inc..

Decision date: 2020-10-01. Decision wording: Substantially Equivalent.

Product code: CEM. Regulation: 21 CFR 862.1600. Medical specialty: Clinical Chemistry.

This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.